Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Daewoong Pharmaceutical patents JAK3 inhibitors

June 18, 2021

4SC and NKI collaborate to study neoadjuvant domatinostat in urothelial carcinoma

June 18, 2021

DSMB recommends phase I trial of rhenium nanoliposomes in GBM proceed to next cohort

June 17, 2021

Phase I/II trial of eprenetapopt in TP53-mutant AML meets primary efficacy endpoint

June 17, 2021

Safety data presented for BGB-11417 in R/R B-cell malignancies

June 17, 2021

Switching on prodrugs with radiotherapy shows promise

June 17, 2021

Dunad Therapeutics and 2692372 Ontario, Inc. patent compounds for cancer

June 17, 2021

Janssen Pharmaceutica presents new Mcl-1 inhibitors

June 17, 2021

SpringWorks initiates phase I/II study of mirdametinib in children and young adults with LGG

June 17, 2021

ORIN-1001 shows promising preliminary antitumor activity in heavily pretreated solid tumors

June 16, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...